| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (groß) | News + Adhoc | Bilanz/GuV | Termine | Zertifikate | Depot |
| Times + Sales | Chart-Analyse | Analysen | Dividende/HV | Profil | Optionsscheine | Watchlist |
| Börsenplätze | Chartvergleich | Kursziele | Vergleich | Insidertrades | Knock-outs | myHome |
| Orderbuch | Realtime Stuttgart | RSS Feed | im Forum | Fonds | Senden | |
| Historisch | Realtime Push | myNews neu | Ausblick | IR-Daten | Anleihen | handeln |
| Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
|---|---|---|---|---|---|---|
| Vontobel Research | 176,00CHF | +11,04% | 07.05.12 | |||
| Hamburger Sparkasse AG (Haspa) | - | - | 16.04.12 | |||
| Exane-BNP Paribas SA | 190,00CHF | +19,87% | 13.04.12 | |||
| Cheuvreux SA | 170,00CHF | +7,26% | 12.04.12 | |||
| Nomura | 130,00CHF | -17,98% | 11.04.12 | |||
| Credit Suisse Group | 180,00CHF | +13,56% | 05.04.12 | |||
| WestLB AG | - | - | 30.03.12 | |||
| J.P. Morgan Cazenove | - | - | 29.03.12 | |||
| Citigroup Corp. | 157,00CHF | -0,95% | 14.02.12 | |||
| Banc of America Securities-Merrill Lynch | 195,00CHF | +23,03% | 06.02.12 | |||
| Barclays Capital | 186,00CHF | +17,35% | 03.02.12 | |||
| Sarasin Research | - | - | 01.02.12 | |||
| Deutsche Bank AG | 172,00CHF | +8,52% | 24.01.12 | |||
| UniCredit Research | 160,00CHF | +0,95% | 11.10.11 | |||
| Société Générale Group S.A. (SG) | 140,00CHF | -11,67% | 23.09.11 |
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 3 | 1 | 1 | 60,00 $ | -2,23% |
| AstraZeneca plc | 2 | 4 | 5 | 28,21 £ | +8,88% |
| Balda AG | 1 | 0 | 0 | 6,70 € | +56,91% |
| Bayer | 14 | 12 | 0 | 61,14 € | +20,26% |
| Evotec AG | 3 | 0 | 0 | 3,75 € | +68,92% |
| Fresenius Medical Care AG & Co. KGaA (FMC) St. | 15 | 10 | 3 | 58,21 € | +10,71% |
| Fresenius SE & Co. KGaA (St.) | 18 | 4 | 0 | 85,50 € | +13,05% |
| Gilead Sciences Inc. | 10 | 2 | 0 | 57,64 $ | +14,82% |
| GlaxoSmithKline plc (GSK) | 6 | 8 | 1 | 15,34 £ | +10,20% |
| Johnson & Johnson | 5 | 4 | 0 | 70,67 $ | +11,70% |
| Merck Co. | 2 | 3 | 0 | 38,50 $ | +3,11% |
| Merck KGaA | 4 | 17 | 1 | 81,56 € | +7,86% |
| MorphoSys AG | 3 | 3 | 0 | 22,98 € | +30,42% |
| Novartis AG | 10 | 8 | 1 | 56,36 | +14,90% |
| Pfizer Inc. | 7 | 4 | 1 | 23,75 $ | +7,51% |
| QIAGEN N.V. | 8 | 7 | 2 | 13,50 € | +4,41% |
| Roche Holding AG (Inhaberaktie) | 10 | 5 | 0 | 168,73 | +6,45% |
| Sanofi S.A. | 13 | 8 | 2 | 58,80 € | +9,19% |
| STADA Arzneimittel AG (vink. NA) | 9 | 9 | 1 | 25,99 € | +3,96% |